Compare Novartis AG (NVS) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Remitly Global Inc — how do they compare? Novartis AG trades at $149.81 (market cap $290.25B), while Remitly Global Inc trades at $23.93 (market cap $5.02B). The key difference: Novartis AG is far larger — about 57.8× Remitly Global Inc's market cap, and Novartis AG pays a 3.17% dividend while Remitly Global Inc pays none. Which is the better fit depends on your goals.
| NVS | RELY | |
|---|---|---|
Market Cap | $290.25B | $5.02B |
Sector | Health | Technology |
52-Week High | $168.62 | $25.23 |
52-Week Low | $113.50 | $12.20 |
Enterprise Value | $330.27B | $4.41B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
